Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15

ObjectiveThe aim was to conduct an empirical assessment of the measurement properties of the preference-based Child Health Utility 9D (CHU9D) versus the non-preference-based Pediatric Quality of Life Inventory (PedsQL)™ 4.0 Short Form 15 Generic Core Scales (referred to as ‘PedsQL’) in an Australian community-based sample of adolescents.MethodsAn online survey including the CHU9D, the PedsQL, a self-reported general health question, and socio-demographic questions was administered to adolescents (aged 15–17 years). Descriptive summary statistics and psychometric analyses were conducted to assess levels of agreement and convergent validity between the instruments.ResultsA total of 775 adolescents (mean ± SD age 15.8 ± 0.8 years) completed the survey. The mean ± SD scores of the CHU9D and the PedsQL were 0.72 ± 0.22 and 72.86 ± 16.56, respectively. For both instruments, there were significant differences in health-related quality of life scores according to self-reported health status and socio-economic status. Overall, both the Spearman’s correlation (r = 0.63) and the intraclass correlation coefficient (0.77) suggested a high level of agreement.ConclusionsThe findings indicate good levels of agreement overall between the CHU9D and PedsQL and provide further support for the validity of the application of the CHU9D in the economic evaluation of adolescent health care treatment and service programmes.

[1]  Jacob Cohen,et al.  The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability , 1973 .

[2]  Stephen J. Walters,et al.  Quality of Life Outcomes in Clinical Trials and Health-Care Evaluation: A Practical Guide to Analysis and Interpretation , 2009 .

[3]  L. Rajmil,et al.  Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study , 2006, Journal of Epidemiology and Community Health.

[4]  G. Holmbeck,et al.  Adolescent health psychology. , 2002, Journal of consulting and clinical psychology.

[5]  A. Frisén,et al.  Measuring health‐related quality of life in adolescence , 2007, Acta paediatrica.

[6]  Katherine Stevens,et al.  Valuation of the Child Health Utility 9D Index , 2012, PharmacoEconomics.

[7]  Julie Ratcliffe,et al.  A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations , 2015, PharmacoEconomics.

[8]  J. Brazier,et al.  Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study , 2015, Applied Health Economics and Health Policy.

[9]  Julie Ratcliffe,et al.  Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  Stephen J. Walters,et al.  Quality of life outcomes in clinical trials and health-care evaluation , 2009 .

[11]  J. Ratcliffe,et al.  Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment. , 2016, Vaccine.

[12]  J. Varni,et al.  The PedsQL™ as a pediatric patient-reported outcome: reliability and validity of the PedsQL™ Measurement Model in 25,000 children , 2005, Expert review of pharmacoeconomics & outcomes research.

[13]  John Brazier,et al.  An assessment of the construct validity of the CHU9D in the Australian adolescent general population , 2012, Quality of Life Research.

[14]  Mark Carpenter,et al.  The New Statistical Analysis of Data , 2000, Technometrics.

[15]  Katherine Stevens,et al.  Developing a descriptive system for a new preference-based measure of health-related quality of life for children , 2009, Quality of Life Research.

[16]  J. Varni,et al.  The PedsQL™: Reliability and Validity of the Short-Form Generic Core Scales and Asthma Module , 2005, Medical care.

[17]  M. Drummond Introducing economic and quality of life measurements into clinical studies , 2001, Annals of medicine.

[18]  Joffre Swait,et al.  Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. , 2016, Social science & medicine.

[19]  K. Stevens Valuation of the Child Health Utility Index 9D (CHU9D) , 2010 .

[20]  Katherine Stevens,et al.  Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation , 2011, Applied health economics and health policy.

[21]  R. Keren,et al.  Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children , 2012, PharmacoEconomics.

[22]  K. Stevens,et al.  Working With Children to Develop Dimensions for a Preference-Based, Generic, Pediatric, Health-Related Quality-of-Life Measure , 2010, Qualitative health research.

[23]  Alessio Zambon,et al.  The Family Affluence Scale as a Measure of National Wealth: Validation of an Adolescent Self-Report Measure , 2006 .

[24]  S. Kleinert Adolescent health: an opportunity not to be missed , 2007, The Lancet.

[25]  J. Brazier,et al.  Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[26]  John Brazier,et al.  Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[27]  Julie Ratcliffe,et al.  Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15 , 2017, PharmacoEconomics.

[28]  C. Carswell Measuring and Valuing Health Benefits for Economic Valuation , 2007, PharmacoEconomics.

[29]  R. Viney,et al.  Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review , 2015, PharmacoEconomics.